Showing 30 of 3541 posts
Pharos Energy announces a 10% dividend hike, strong net cash position, and active drilling programmes in Vietnam & Egypt. Full analysis inside.
JoshuaMarch 25, 2026
Aptamer Group's H1 2026: 27% revenue growth, first licensing payments in, and strategic push into radiopharma with new fundraise.
JoshuaMarch 25, 2026
Gattaca's H1 2026 profits surge 431%, driven by strong growth in contract recruitment for core Defence, Energy & Infrastructure sectors.
JoshuaMarch 24, 2026
Record $45.4m EBITDA and 24.7% revenue growth. PPHC's 2025 results show a powerful surge post-US IPO and strategic M&A.
JoshuaMarch 24, 2026
Everplay's FY 2025 profit jumped 44% to £36.6m as margins expanded. Strategic shift to higher-quality releases drove growth despite flat revenue. Analysis inside.
JoshuaMarch 24, 2026
Journeo reports record £55m revenue for 2025, with 40% gross margin and strategic entry into critical infrastructure protection via CFDS acquisition.
JoshuaMarch 24, 2026
S4 Capital's 2025 results show revenue fell 10.8% but cost control boosted margins and cash flow, as its AI strategy aims to reshape future growth.
JoshuaMarch 24, 2026
The Pebble Group's ESG report reveals a 16% cut in carbon emissions and the launch of its net-zero strategy for 2025.
JoshuaMarch 24, 2026
YouGov's H1 profit rose 14% as it reviews its Shopper division and plans a share buyback to replace its dividend, signalling a strategic pivot.
JoshuaMarch 24, 2026
TMT Investments' NAV rose 8.9% in 2025, powered by AI star Scale AI and portfolio gains, while buybacks at a steep discount boosted shareholder value.
JoshuaMarch 24, 2026
PZ Cussons Q3 update: Like-for-like revenue grows 6.3%, with adjusted operating profit now guided to the upper end of its £53-57 million range.
JoshuaMarch 24, 2026
Bytes Technology posts FY26 results with strong cash generation and strategic realignment. FY27 outlook targets growth amid cost normalisation. Read the full analysis.
JoshuaMarch 24, 2026
Chesnara's 2025 results reveal a transformative year: the completed HSBC Life acquisition boosts scale and long-term cash flow, while a 6% dividend hike rewards shareholders.
JoshuaMarch 24, 2026
CPH2 signs non-binding MOU with Siemens to scale up its membrane-free electrolyser production, gaining industrial expertise and market access.
JoshuaMarch 24, 2026
Staffline smashes FY 2025 forecasts with double-digit growth, surging profits, and a major share buyback program.
JoshuaMarch 24, 2026
Corero's 2025 results: H2 acceleration drives 23% ARR growth to $23.9M, with subscription transition boosting momentum into 2026.
JoshuaMarch 24, 2026
EKF Diagnostics' FY 2025 results show 9.3% adjusted EBITDA growth, thriving margins, strong cash flow & a clear five-year strategic blueprint. Analysis inside.
JoshuaMarch 24, 2026
BioPharma Credit's strong 2025: Higher net income per share, fully covered dividends, and a cash war chest for new deals.
JoshuaMarch 24, 2026
Distil warns of revenue shortfall due to trade destocking, despite strong consumer demand. Immediate funding need and US launch delay add pressure. Analysis inside.
JoshuaMarch 24, 2026
Michelmersh Brick's 2025 results: profit squeeze, CFO steps down, but dividend steady amid market challenges.
JoshuaMarch 24, 2026
Flowtech Fluidpower reports 30.5% underlying EBITDA growth, enters new 'grow and build' phase after strong second-half turnaround.
JoshuaMarch 24, 2026
Fevertree’s FY25 results show steady brand revenue growth and strong diversification, but profitability dipped due to US transition costs and an environmental levy provision.
JoshuaMarch 24, 2026
Record Hallam Land plot sales and strategic refocus anchor Henry Boot's resilient 2025 results, as higher net debt and homebuilding losses pose challenges.
JoshuaMarch 24, 2026
Personal Group beats FY25 expectations with 22% EBITDA growth and a 41% dividend hike, backed by a 90% recurring revenue engine.
JoshuaMarch 24, 2026
Xaar's 2025 results show adjusted profit back in black, driven by 22% printhead growth and a commercial breakthrough in jewellery wax 3D printing.
JoshuaMarch 24, 2026
Tandem Group's FY25: profits beat forecasts, dividend reinstated at 3.0p, and net debt more than halved to £1.9m.
JoshuaMarch 23, 2026
Blackbird's 2025 results show cost discipline, a profitable core division, and early growth for its elevate.io video editor with 138k users and a 1.1% paid conversion rate.
JoshuaMarch 23, 2026
PGPE Ltd's 2025 results show an 8.7% NAV decline but a 5.3% share price rise. With a 19.6% discount, the Board is reviewing strategic options to boost liquidity and narrow the gap.
JoshuaMarch 23, 2026
Applied Nutrition's H1 FY26 interim results show 56.5% revenue growth to £74.5m, with stable margins and £140m full-year guidance.
JoshuaMarch 23, 2026
Built Cybernetics returns to profit in 2025 as its pivot to software pays off, with proprietary recurring revenue surging 69% to £751k.
JoshuaMarch 23, 2026